DK464578A - Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf - Google Patents

Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf

Info

Publication number
DK464578A
DK464578A DK464578A DK464578A DK464578A DK 464578 A DK464578 A DK 464578A DK 464578 A DK464578 A DK 464578A DK 464578 A DK464578 A DK 464578A DK 464578 A DK464578 A DK 464578A
Authority
DK
Denmark
Prior art keywords
substituted
carxylic
amies
azabicyclo
hept
Prior art date
Application number
DK464578A
Other languages
English (en)
Inventor
B C Christensen
D B R Johnston
S M Schmitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK464578A publication Critical patent/DK464578A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK464578A 1977-10-19 1978-10-18 Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf DK464578A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84337877A 1977-10-19 1977-10-19

Publications (1)

Publication Number Publication Date
DK464578A true DK464578A (da) 1979-06-28

Family

ID=25289794

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464578A DK464578A (da) 1977-10-19 1978-10-18 Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf

Country Status (9)

Country Link
EP (1) EP0001628B1 (da)
JP (1) JPS5466697A (da)
AU (1) AU531084B2 (da)
DE (1) DE2862364D1 (da)
DK (1) DK464578A (da)
ES (1) ES474288A1 (da)
IE (1) IE47958B1 (da)
IT (1) IT1109318B (da)
ZA (1) ZA785858B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
US4263314A (en) * 1978-01-19 1981-04-21 Beecham Group Limited β-Lactam antibiotics, a process for their preparation and their use in pharmaceutical compositions
EP0008888B1 (en) * 1978-08-23 1983-09-21 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
EP0008514B1 (en) * 1978-08-25 1982-01-20 Beecham Group Plc Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
IE51861B1 (en) * 1978-10-24 1987-04-15 Merck & Co Inc 6-,1-and 2-substituted-1-carbapen-2-em-3-carboxylic acids,processes for the preparation of such compounds and pharmaceutical compositions comprising such compounds
EP0011173B1 (en) * 1978-11-01 1983-05-11 Sanraku-Ocean Co., Ltd. Process for producing antibiotic beta-lactam compounds
JPS5622787A (en) * 1979-07-27 1981-03-03 Sanraku Inc Beta-lactam compound
JPS55136282A (en) * 1979-04-06 1980-10-23 Shionogi & Co Ltd Novel antibiotic pa-31088-4
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
JPS5610165A (en) * 1979-07-05 1981-02-02 Sumitomo Chem Co Ltd Novel beta-lactam compound and its production
DE3164021D1 (en) * 1980-01-25 1984-07-19 Beecham Group Plc Beta-lactam containing compounds, their preparation and use
US4409147A (en) * 1980-03-10 1983-10-11 Takeda Chemical Industries, Ltd. Carbapenem compounds and their production
JPS56145271A (en) * 1980-04-11 1981-11-11 Dai Ichi Seiyaku Co Ltd 2-azetidinone derivative
JPS56161393A (en) * 1980-05-16 1981-12-11 Sanraku Inc Beta-lactam compound
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
EP0050927B1 (en) * 1980-10-25 1985-03-27 Beecham Group Plc The preparation of beta-lactam antibiotics
US4361512A (en) * 1980-11-26 1982-11-30 Merck & Co., Inc. 2-Substituted thio-6-substituted-carbapen-2-em-3-carboxylic acids
WO1982001871A1 (en) * 1980-12-03 1982-06-10 Ochiai Michihiko Process for preparing a 1-sulfo-2-oxoazetidine derivative
EP0059554A3 (en) * 1981-02-27 1982-10-20 Beecham Group Plc Beta-lactam antibiotics, a process for their preparation and their use in pharmaceutical compositions
CA1198440A (en) * 1982-04-08 1985-12-24 Choung U. Kim Carbapenem antibiotics
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
EP0093915A1 (en) * 1982-05-10 1983-11-16 Gruppo Lepetit S.P.A. Novel beta-lactam derivatives
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
EP0105658A1 (en) * 1982-09-28 1984-04-18 Beecham Group Plc Beta-lactam compounds
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
NL7612937A (nl) * 1975-11-21 1977-05-24 Merck & Co Inc Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
NL7712093A (nl) * 1976-11-19 1978-05-23 Merck & Co Inc Werkwijze voor het bereiden van isomere thienamycinen.
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DE2862198D1 (en) * 1977-08-06 1983-04-14 Beecham Group Plc Synthetic beta-lactam compounds, a process for their preparation and compositions containing them
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes

Also Published As

Publication number Publication date
IE47958B1 (en) 1984-08-08
ZA785858B (en) 1980-05-28
EP0001628A1 (en) 1979-05-02
JPH0215552B2 (da) 1990-04-12
JPS5466697A (en) 1979-05-29
IT1109318B (it) 1985-12-16
AU531084B2 (en) 1983-08-11
ES474288A1 (es) 1980-01-16
AU4061478A (en) 1980-04-17
EP0001628B1 (en) 1984-01-18
IE782070L (en) 1979-04-19
IT7851567A0 (it) 1978-10-18
DE2862364D1 (en) 1984-02-23

Similar Documents

Publication Publication Date Title
DK464578A (da) Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf
DK464478A (da) Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf
DK421879A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK13878A (da) Fremgangsmaade til fremstilling af 11beta-substituerede 4,9-diensteroider
DK421979A (da) Formstofnet og fremgangsmaade til fremstilling af dette
DK15279A (da) Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK498080A (da) Fremgangsmaade til fremstilling af 4!-epidaunorubicin, 3!,4!-diepidaunorubicin og disses doxorubicinanaloge
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK180878A (da) Fremgangsmaade til fremstilling af imidazoaziner og imidazodiaziner
DK142180A (da) Fremgangsmaade til fremstilling af 6-substituerede pyranon-derivater
DK105379A (da) Fremgangsmaade til fremstilling af flavan eller flavanderivater
DK149586C (da) Fremgangsmaade til fremstilling af 1-amino-cyclopropan-carboxylsyre og derivater deraf
DK13978A (da) Fremgangsmaade til fremstilling af 11betasubstituerede 1,3,5(,0)-triensteroider
DK163379A (da) Fremgangsmaade til fremstilling af substituerede 1,3-diaryl-2-imino-imidazolidiner og 2-imino-hexahydro-pyrimidiner
NO790934L (no) 2,6-dialkoksybenzamider og fremgangsmaate til deres fremstilling
DK236477A (da) Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK326378A (da) Fremgangsmaade til fremstilling af 2,3,6-substituerede 4-pyroner
DK465578A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner
DK483378A (da) Fremgangsmaade til fremstilling af 2,4-difluoranilin
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK142080A (da) Fremgangsmaade til fremstilling af 6-substituerede pyranon-derivater
DK142578C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-benzylpyrimidiner og syreadditionssalte deraf
DK548478A (da) Fremgangsmaade til fremstilling af 2,4,5-trichlorphenol

Legal Events

Date Code Title Description
ATS Application withdrawn